Improving Outcomes of Tyrosine Kinase Inhibitors in Hepatocellular Carcinoma: New Data and Ongoing Trials.
Mou L, Tian X, Zhou B, Zhan Y, Chen J, Lu Y, Deng J, Deng Y, Wu Z, Li Q, Song Y, Zhang H, Chen J, Tian K, Ni Y, Pu Z.
Mou L, et al. Among authors: li q.
Front Oncol. 2021 Oct 11;11:752725. doi: 10.3389/fonc.2021.752725. eCollection 2021.
Front Oncol. 2021.
PMID: 34707994
Free PMC article.
Review.